Wealthspire Advisors (New York)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $726K | Sell |
|
|||||
|
2025
Q2 | $800K | Buy |
|
|||||
|
2025
Q1 | $835K | Buy |
|
|||||
|
2024
Q4 | $717K | Buy |
|
|||||
|
2024
Q3 | $681K | Sell |
|
|||||
|
2024
Q2 | $562K | Hold |
|
|||||
|
2024
Q1 | $578K | Hold |
|
|||||
|
2023
Q4 | $610K | Hold |
|
|||||
|
2023
Q3 | $424K | Sell |
|
|||||
|
2023
Q2 | $528K | Hold |
|
|||||
|
2023
Q1 | $651K | Buy |
|
|||||
|
2022
Q4 | $645K | Buy |
|
|||||
|
2022
Q3 | $440K | Sell |
|
|||||
|
2022
Q2 | $580K | Hold |
|
|||||
|
2022
Q1 | $686K | Sell |
|
|||||
|
2021
Q4 | $933K | Sell |
|
|||||
|
2021
Q3 | $1.79M | Hold |
|
|||||
|
2021
Q2 | $1.94M | Hold |
|
|||||
|
2021
Q1 | $1.56M | Hold |
|
|||||
|
2020
Q4 | $1.13M | Hold |
|
|||||
|
2020
Q3 | $1M | Hold |
|
|||||
|
2020
Q2 | $1.56M | Hold |
|
|||||
|
2020
Q1 | $1.3M | Buy |
|